| Cat. No. |
Product Name |
Information |
| PC-35441 |
Cimlanod
HNO donor
|
Cimlanod is a second-generation nitroxyl (HNO) donor, delivers HNO via pH-dependent chemical breakdown when exposed to the neutral pH environment of the bloodstream, shows positive lusitropic and inotropic as well as vasodilatory effects. |
| PC-35430 |
BIO124
PICK1-GluA2 inhibitor
|
BIO124 (BIO-124) is a modest inhibitor of the PICK1-GluA2 interaction with IC50 of 0.51 uM in FP assays, binds to the PDZ domain of PICK1. |
| PC-35415 |
Desmethyl dabrafenib
|
Desmethyl dabrafenib (GSK2167542, Dabrafenib metabolite M8) is the desmethyl- metabolic byproduct of Dabrafenib, ameliorates developmental pathologies of Kabuki Syndrome in vivo.. |
| PC-35412 |
GAK inhibitor 49
GAK inhibitor
|
GAK inhibitor 49 is a potent, selective, ATP-competitive inhibitor of cyclin G-associated kinase (GAK, cell IC50=56 nM) with favourable NAK family selectivity (AAK1, STK16, BMP2K). |
| PC-35411 |
GAK inhibitor 12r
GAK inhibitor
|
GAK inhibitor 12r is a higghly potent, selective inhibitor of cyclin G-associated kinase (GAK) with Kd of 89 nM. |
| PC-35410 |
IGS-1.76
NCS-1/Ric8a inhibitor
|
IGS-1.76 is a small molecule inhibitor of human NCS-1/Ric8a interaction with affinity of 1.25 uM (hNCS-1). |
| PC-35386 |
FTBMT
GPR52 agonist
|
FTBMT (TP024) is a novel selective GPR52 agonist, increases intracellular cAMP levels in CHO cells expressing human, mouse, or rat GPR52, with pEC50 of 7.03, 6.85, and 6.87M, respectively. |
| PC-35376 |
SOD1-Derlin-1 inhibitor 56-59
|
SOD1-Derlin-1 inhibitor 56-59 is a cell-permeable, small molecule inhibitor of SOD1-Derlin-1 interaction, target SOD1 DBR and clearly attenuates the interactions of Derlin-1 with 122 types of SOD1mut in the cell-based co-immunoprecipitation assays. |
| PC-35371 |
Edonerpic maleate
CRMP2 inhibitor, Aβ inhibitor
|
Edonerpic maleate (T-817MA) is a neurotrophic agent that can protects neuronal cells and modifies their morphology, binds to collapsin-response-mediator-protein 2 (CRMP2) and inhibits amyloid-β peptides (Aβ). |
| PC-35366 |
Lipofermata
FATP2 inhibitor
|
Lipofermata (CB16.2 aka) is a specific fatty acid transport (FATP) inhibitor, blocks human FATP2-mediated fatty acid uptake (IC50=4.84 uM in Caco-2 cells) without impacting other cellular functions. |
| PC-35343 |
5MPN
PFKFB4 inhibitor
|
PFKFB4 inhibitor 5MPN is a first-in-class, selective, competitive, orally available inhibitor of PFKFB4 with Ki of 8.6 uM, does not inhibit PFK-1 or PFKFB3. |
| PC-35335 |
CPSI-1306
MIF inhibitor
|
CPSI-1306 (CPSI1306) is an orally available small-molecule MIF antagonist, protects against UVB-induced squamous cell carcinoma, reduces the severity of animal model of multiple sclerosis. |
